Vitamin D3

Patients with asthma who used vitamin D3 supplements experienced less severe disease, fewer daytime symptoms and better symptom control, according to research published in The Journal of Allergy and Clinical Immunology: Global.

Weekly vitamin D supplements increased 25-hydroxyvitamin D concentrations but did not affect growth or body composition among school-aged children, according to researchers.

Compared with placebo, researchers found that vitamin D3 supplementation did not significantly reduce statin-associated muscle symptoms.

Vitamin D3 supplementation was not associated with reduced statin-associated muscle symptoms compared with placebo among new statin users enrolled in the VITAL trial, according to a trial subanalysis published in JAMA Cardiology.

Supplementation with vitamin D3 and omega-3 fatty acids did not significantly reduce frailty risk in older adults, a study published in JAMA Network Open found.

A new analysis of the VITAL trial showed that vitamin D3 supplementation did not significantly reduce fracture risk compared with placebo in adults without vitamin D deficiency or osteoporosis. It was the top story in endocrinology last week.

Vitamin D3 supplementation did not reduce fracture risk in a large cohort of U.S. adults not selected for vitamin D deficiency or osteoporosis, according to an ancillary analysis of the VITAL trial.

Four of the five top stories in cardiology last week were based on presentations from the virtual American Heart Association Scientific Sessions.

Taking omega-3 fatty acids and vitamin D3 supplements did not increase nor decrease the risk for incident atrial fibrillation over 5 years, according to results of the VITAL Rhythm trial.

Vitamin D3 supplementation showed no improvement in clinical or radiographic fracture healing in adult patients who underwent intramedullary nailing for a tibial or femoral shaft fracture, according to presented results.